171 related articles for article (PubMed ID: 33259941)
1. Immunohistochemical localization of prolactin receptor (PRLR) to Hodgkin's and Reed-Sternberg cells of Hodgkin's lymphoma.
Gharbaran R; Onwumere O; Codrington N; Somenarain L; Redenti S
Acta Histochem; 2021 Jan; 123(1):151657. PubMed ID: 33259941
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
Doussis-Anagnostopoulou IA; Talks KL; Turley H; Debnam P; Tan DC; Mariatos G; Gorgoulis V; Kittas C; Gatter KC
J Pathol; 2002 Aug; 197(5):677-83. PubMed ID: 12210089
[TBL] [Abstract][Full Text] [Related]
3. Characterization of NF-kappaB expression in Hodgkin's disease: inhibition of constitutively expressed NF-kappaB results in spontaneous caspase-independent apoptosis in Hodgkin and Reed-Sternberg cells.
Izban KF; Ergin M; Huang Q; Qin JZ; Martinez RL; Schnitzer B; Ni H; Nickoloff BJ; Alkan S
Mod Pathol; 2001 Apr; 14(4):297-310. PubMed ID: 11301346
[TBL] [Abstract][Full Text] [Related]
4. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
van den Berg A; Visser L; Poppema S
Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of cell cycle regulators in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma.
Tzankov A; Zimpfer A; Went P; Maurer R; Pileri SA; Geley S; Dirnhofer S
Mod Pathol; 2005 Jan; 18(1):90-6. PubMed ID: 15389259
[TBL] [Abstract][Full Text] [Related]
6. The side population, as a precursor of Hodgkin and Reed-Sternberg cells and a target for nuclear factor-κB inhibitors in Hodgkin's lymphoma.
Nakashima M; Ishii Y; Watanabe M; Togano T; Umezawa K; Higashihara M; Watanabe T; Horie R
Cancer Sci; 2010 Nov; 101(11):2490-6. PubMed ID: 20735433
[TBL] [Abstract][Full Text] [Related]
7. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
Skinnider BF; Elia AJ; Gascoyne RD; Patterson B; Trumper L; Kapp U; Mak TW
Blood; 2002 Jan; 99(2):618-26. PubMed ID: 11781246
[TBL] [Abstract][Full Text] [Related]
8. Effects of vitamin D3 and its chemical analogs on the growth of Hodgkin's lymphoma, in vitro.
Gharbaran R; Zhang B; Valerio L; Onwumere O; Wong M; Mighty J; Redenti S
BMC Res Notes; 2019 Apr; 12(1):216. PubMed ID: 30961641
[TBL] [Abstract][Full Text] [Related]
9. Proliferation profile of classical Hodgkin's lymphomas. Increased expression of the protein cyclin D2 in Hodgkin's and Reed-Sternberg cells.
Bai M; Tsanou E; Agnantis NJ; Kamina S; Grepi C; Stefanaki K; Rontogianni D; Galani V; Kanavaros P
Mod Pathol; 2004 Nov; 17(11):1338-45. PubMed ID: 15354186
[TBL] [Abstract][Full Text] [Related]
10. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW
Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270
[TBL] [Abstract][Full Text] [Related]
11. The B7/BB1 antigen is expressed by Reed-Sternberg cells of Hodgkin's disease and contributes to the stimulating capacity of Hodgkin's disease-derived cell lines.
Delabie J; Ceuppens JL; Vandenberghe P; de Boer M; Coorevits L; De Wolf-Peeters C
Blood; 1993 Nov; 82(9):2845-52. PubMed ID: 7693051
[TBL] [Abstract][Full Text] [Related]
12. Rare expression of T-cell markers in classical Hodgkin's lymphoma.
Tzankov A; Bourgau C; Kaiser A; Zimpfer A; Maurer R; Pileri SA; Went P; Dirnhofer S
Mod Pathol; 2005 Dec; 18(12):1542-9. PubMed ID: 16056244
[TBL] [Abstract][Full Text] [Related]
13. Aberrant FHIT protein expression in classical Hodgkin's lymphoma: a potential marker.
Zhao P; Lam AK; Lu YL; Zhong M; Chen LH; Pu XL
Pathology; 2006 Oct; 38(5):399-402. PubMed ID: 17008276
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study.
Vandenberghe P; Wlodarska I; Tousseyn T; Dehaspe L; Dierickx D; Verheecke M; Uyttebroeck A; Bechter O; Delforge M; Vandecaveye V; Brison N; Verhoef GE; Legius E; Amant F; Vermeesch JR
Lancet Haematol; 2015 Feb; 2(2):e55-65. PubMed ID: 26687610
[TBL] [Abstract][Full Text] [Related]
15. Clinical drug-resistant nodular sclerosing Hodgkin's lymphoma is associated with decreased bcl-2 expression in the surrounding lymphocytes and with increased bcl-2 expression in the Reed-Sternberg cells.
van Spronsen DJ; Peh SC; Vrints LW; van Imhoff GW; Poppema S
Histopathology; 2000 Nov; 37(5):420-6. PubMed ID: 11119123
[TBL] [Abstract][Full Text] [Related]
16. Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of Hodgkin and Reed-Sternberg cells.
Izban KF; Ergin M; Martinez RL; Alkan S
Mod Pathol; 2000 Dec; 13(12):1324-31. PubMed ID: 11144929
[TBL] [Abstract][Full Text] [Related]
17. Dynamic chromosomal rearrangements in Hodgkin's lymphoma are due to ongoing three-dimensional nuclear remodeling and breakage-bridge-fusion cycles.
Guffei A; Sarkar R; Klewes L; Righolt C; Knecht H; Mai S
Haematologica; 2010 Dec; 95(12):2038-46. PubMed ID: 20823137
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of oncogenic properties and nuclear factor-kappaB activity of latent membrane protein 1 natural variants from Hodgkin's lymphoma's Reed-Sternberg cells and normal B-lymphocytes.
Faumont N; Chanut A; Benard A; Cogne N; Delsol G; Feuillard J; Meggetto F
Haematologica; 2009 Mar; 94(3):355-63. PubMed ID: 19211641
[TBL] [Abstract][Full Text] [Related]
19. Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.
Vockerodt M; Wei W; Nagy E; Prouzova Z; Schrader A; Kube D; Rowe M; Woodman CB; Murray PG
J Pathol; 2013 Aug; 230(4):399-409. PubMed ID: 23592216
[TBL] [Abstract][Full Text] [Related]
20. PKCeta expression contributes to the resistance of Hodgkin's lymphoma cell lines to apoptosis.
Abu-Ghanem S; Oberkovitz G; Benharroch D; Gopas J; Livneh E
Cancer Biol Ther; 2007 Sep; 6(9):1375-80. PubMed ID: 17786031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]